Key points are not available for this paper at this time.
Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer. The regimen was associated with acceptable adverse-event rates. (Funded by the Dutch Cancer Foundation KWF Kankerbestrijding; Netherlands Trial Register number, NTR487.).
Hagen et al. (2012) studied this question.